A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study)
Katie O’Hearn, Valentina Catalan(Clínica Alemana), Stephanie Redpath(University of Ottawa), Siegfried Roedl(Medical University of Graz), Glenville Jones(Queen's University), Margaret L. Lawson(Children's Hospital of Eastern Ontario), Kusum Menon(University of Ottawa), Anne Tsampalieros(Children's Hospital of Eastern Ontario), Nick Barrowman(Royal University Hospital), Hope A. Weiler(Health Canada), Raúl Bustos(Clínica Alemana), Dean Fergusson(Ottawa Hospital), James Dayre McNally(Children's Hospital of Eastern Ontario), Karin Amrein(Medical University of Graz), Anna Gunz(Western University), Pavel Geier(University of Ottawa), Lauralyn McIntyre(Ottawa Hospital Research Institute), Matthew Henderson(Gartnavel General Hospital), Martin Kaufmann(Robert Bosch Hospital), Ali Khamessan, Roberto Augusto de Carvalho Campos(Clínica Alemana)
Cited by 6
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k